MedTrace Logo

Bone Level Tapered Multi-Center Study

NCT02569671 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2026-05-05

Study results available
· View outcomes & findings →

Summary

The aim of this randomized, controlled, multi-center study is to assess the clinical and radiographic outcomes of using a Straumann® Bone Level Tapered implant for immediate implantation following extraction of a tooth in the pre-molar and anterior region of the maxilla and mandible (test) compared to the outcomes of placing this implant in healed sites (control).

Conditions

  • Tooth Loss

Interventions

DEVICE

Straumann Bone Level Tapered Implant - Immediate Placement

Immediate placement of a Straumann Bone Level Tapered Dental Implant for replacement of a singe tooth.

DEVICE

Straumann Bone Level Tapered Implant - Delayed Placement

Delayed placement of a Straumann Bone Level Tapered Dental Implant for replacement of a singe tooth.

Sponsors & Collaborators

  • Institut Straumann AG

    lead INDUSTRY

Principal Investigators

  • David L. Cochran, DDS, PhD, MS · The University of Texas Health Science Center at San Antonio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-11-12
Completion
2025-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02569671 on ClinicalTrials.gov